Stockscreener 앱 받기
2.14
7.00%
0.14
시간 외 거래:
2.08
-0.06
-2.80%
전일 마감가:
$2.00
열려 있는:
$2
하루 거래량:
55,802
Relative Volume:
0.55
시가총액:
$5.07M
수익:
$102.80K
순이익/손실:
$-5.32M
주가수익비율:
-0.5632
EPS:
-3.8
순현금흐름:
$-5.45M
1주 성능:
-3.17%
1개월 성능:
-56.94%
6개월 성능:
-27.70%
1년 성능:
-61.92%
1일 변동 폭
$2.00
$2.24
1주일 범위
$1.9516
$2.50
52주 변동 폭
$1.92
$6.90
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
명칭
Creative Medical Technology Holdings Inc
전화
480-399-2822
주소
211 E. OSBORN RD., PHOENIX
CELZ을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CELZ
Creative Medical Technology Holdings Inc
|
2.14 | 5.07M | 102.80K | -5.32M | -5.45M | -3.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.49 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
625.60 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
583.62 | 35.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.83 | 34.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
274.78 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Creative Medical Technology Holdings Inc 주식(CELZ)의 최신 뉴스
Creative Medical Technology (NASDAQ:CELZ) versus Immunocore (NASDAQ:IMCR) Head to Head Comparison - Defense World
CELZ stock touches 52-week low at $1.95 amid market challenges - Investing.com Australia
Creative Medical Technology Holdings, Inc. (CELZ) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Creative Medical Technology (CELZ) to Release Quarterly Earnings on Friday - The AM Reporter
Is Creative Medical Technology Holdings, Inc. (CELZ) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Mergers & Acquisitions Tracker - Plastics News
What is Roth Capital’s Forecast for CELZ FY2027 Earnings? - Defense World
Creative Medical Technology (CELZ) Expected to Announce Quarterly Earnings on Friday - Defense World
Creative Medical Technology Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView
FDA approves expanded trial for back pain cell therapy By Investing.com - Investing.com South Africa
Creative Medical Technology Holdings Secures FDA Clearance For Expanded Dosing In Back Pain Trial - Nasdaq
FDA approves expanded trial for back pain cell therapy - Investing.com India
Creative Medical Receives FDA Approval to Expand Dosing in Back Pain Trial -March 20, 2025 at 08:27 am EDT - MarketScreener
Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain - The Manila Times
Nanoparticle Drug Delivery Market Growth, Generated - openPR.com
Creative Medical Technology Holdings Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView
Game-Changing: Family-Owned Business Thrives for Over a Century - GeeksULTD
Just Revealed: Crescent Market Beaumont Family-Owned for 100+ Years - GeeksULTD
Apple Stock Forecast: Where Will It Be In 5 Years? - GeeksULTD
Revolutionary: Stem Cell Therapy Puts Creative Medical on Profit Track - GeeksULTD
Sexual Assault in South Sudan: Experts Stunned by Breakthrough Technology - GeeksULTD
Creative Medical Technology Holdings, Inc.'s (NASDAQ:CELZ) Shift From Loss To Profit - Yahoo
When Will Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Become Profitable? - Simply Wall St
Delaware Court Just Changed the Game for Big Business - GeeksULTD
Shocking: Trump Tariffs Spark Market Sell-Off - GeeksULTD
Trump Tariffs in Chaos: Markets React - GeeksULTD
Revolutionary: Medical Stem Cells Unlock Profit for CELZ - GeeksULTD
Breaking: Trump Trade War Exposes Hidden Dangers - GeeksULTD
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. SEC 10-K Report - TradingView
Hyde Park Capital Advises Infiniti Medical on its Sale to CIMA Animal Health, a Portfolio Company of Incline Equity Partners - The Malaysian Reserve
Exosomes Drug Market Detailed In New Research Report 2025 | Thermo Fisher Scientific, Inc., Bio-Techne - openPR
Exosomes Market Projected To Witness Substantial Growth, 2025-2032: Bio-Techne, QIAGEN, Lonza, Miltenyi - EIN News
Creative Medical Technology secures $3.7 million through warrants By Investing.com - Investing.com Australia
Where are the Opportunities in (CELZ) - Stock Traders Daily
Creative Medical Technology secures $3.7 million through warrants - Investing.com India
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross - EIN News
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds - The Manila Times
Heritage Distilling Co. Announces Recent Achievements and Key Milestones for Salute Series Line of Premium Whiskeys - The Manila Times
Creative Medical Technology Holdings Announces Agreements For Exercise Of Warrants For $3.7 Million Gross Proceeds - MENAFN.COM
Can This $3.7M Cash Injection Fuel Creative Medical's Next Growth Phase? - StockTitan
Head to Head Analysis: Cognition Therapeutics (NASDAQ:CGTX) versus Creative Medical Technology (NASDAQ:CELZ) - Defense World
Rhumbline Advisers Sells 16,291 Shares of DNOW Inc. (NYSE:DNOW) - Defense World
Rhumbline Advisers Sells 7,443 Shares of WisdomTree, Inc. (NYSE:WT) - Defense World
Astrana Health, Inc. (NASDAQ:ASTH) Shares Sold by Rhumbline Advisers - Defense World
Rhumbline Advisers Acquires 3,900 Shares of Vertex, Inc. (NASDAQ:VERX) - Defense World
Rhumbline Advisers Cuts Position in American Assets Trust, Inc. (NYSE:AAT) - Defense World
Rhumbline Advisers Purchases 3,454 Shares of Spirit AeroSystems Holdings, Inc. (NYSE:SPR) - Defense World
Rhumbline Advisers Sells 314 Shares of S&T Bancorp, Inc. (NASDAQ:STBA) - Defense World
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Short Interest Update - Defense World
Embecta Corp. (NASDAQ:EMBC) Shares Sold by Rhumbline Advisers - Defense World
Rhumbline Advisers Reduces Position in TowneBank (NASDAQ:TOWN) - Defense World
Creative Medical Technology Holdings Inc (CELZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.00%
자본화:
|
볼륨(24시간):